ICAM1 and myalgic encephalomeyelitis/chronic fatigue syndrome: Given their concomitant enhanced release from cultured ECs, it can be speculated that patient sera mediated VCAM-1 and ICAM-1 shedding, whereas the latter molecule was only affected by PCS/CFS serum.